menu search

CSII / Cardiovascular Systems, Inc. (CSII) Q1 2023 Earnings Call Transcript

Cardiovascular Systems, Inc. (CSII) Q1 2023 Earnings Call Transcript
Cardiovascular Systems, Inc. (NASDAQ:CSII ) Q1 2023 Results Conference Call November 3, 2022 9:00 AM ET Company Participants Jack Nielsen - Vice President of Investor Relations Scott Ward - Chairman, President and Chief Executive Officer Jeff Points - Chief Financial Officer Conference Call Participants Chris Pasquale - Nephron Research Michael Matson - Needham & Company Suraj Kalia - Oppenheimer Mathew Blackman - Stifel Jayson Bedford - Raymond James Operator Hello, everyone, and welcome to the Cardiovascular Systems, Inc., Fiscal 2023 First Quarter Earnings Conference Call. My name is Seth, and I'll be the operator for your call today [Operator Instructions]. Read More
Posted: Nov 5 2022, 13:58
Author Name: Seeking Alpha
Views: 112571

CSII News  

Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment

By Zacks Investment Research
April 5, 2023

Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment

Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calc more_horizontal

Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes

By Zacks Investment Research
March 20, 2023

Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes

Tough competition and consistent net loss continue to pose threats to Cardiovascular Systems (CSII). more_horizontal

Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors

By Seeking Alpha
February 15, 2023

Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors

Abbott Laboratories expands its cardiovascular pipeline with the relatively small acquisition of Cardiovascular Systems, Inc. Cardiovascular Systems i more_horizontal

Cardiovascular Systems (CSII) Q2 Earnings, Revenues Miss

By Zacks Investment Research
February 10, 2023

Cardiovascular Systems (CSII) Q2 Earnings, Revenues Miss

With the announcement of the merger agreement with Abbott, Cardiovascular Systems (CSII) refrains from providing any update on the 2023 guidance. more_horizontal

Why Cardiovascular Systems Stock Is Soaring Today

By The Motley Fool
February 9, 2023

Why Cardiovascular Systems Stock Is Soaring Today

The medtech company has agreed to a buyout offer from Abbott Laboratories. more_horizontal

Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?

By InvestorPlace
February 9, 2023

Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?

Cardiovascular Systems (NASDAQ: CSII ) stock is rising higher on Thursday following news that Abbott (NYSE: ABT ) intends to acquire the company. That more_horizontal

Cardiovascular Systems shares jump after deal to be bought by Abbott for $890 million

By Market Watch
February 9, 2023

Cardiovascular Systems shares jump after deal to be bought by Abbott for $890 million

Cardiovascular Systems CSII, -1.99% shares rose 47% to $19.58 in early premarket trade after Abbott ABT, -1.60% agreed to buy the company for $890 mil more_horizontal

Cardiovascular Systems (CSII) Reports Q2 Loss, Misses Revenue Estimates

By Zacks Investment Research
February 8, 2023

Cardiovascular Systems (CSII) Reports Q2 Loss, Misses Revenue Estimates

Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -33.33% and 2.70%, respectively, for the quarter ended December 2022. Do the more_horizontal


Search within

Pages Search Results: